Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JT5I
|
||||
Former ID |
DIB018024
|
||||
Drug Name |
PF-04457845
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Liver disease [ICD9: 570-574; ICD10:K70-K77] | Phase 2 | [541799] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H20F3N5O2
|
||||
InChI |
InChI=1S/C23H20F3N5O2/c24-23(25,26)18-6-7-21(27-15-18)33-19-4-1-3-17(14-19)13-16-8-11-31(12-9-16)22(32)29-20-5-2-10-28-30-20/h1-7,10,13-15H,8-9,11-12H2,(H,29,30,32)
|
||||
InChIKey |
BATCTBJIJJEPHM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [531512] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.